Piezo-ICSI: Advanced Microinjection Technology for Higher Fertilization Rates and Improved Oocyte Survival

Piezo-ICSI: Advanced Microinjection Technology for Higher Fertilization Rates and Improved Oocyte Survival

*1. Definition and Mechanism of Action*  
Piezo-ICSI is an advanced micromanipulation technique developed in Japan for oocytes with fragile membranes. The system employs a piezoelectric actuator PMM4G that converts electrical signals into precise high-frequency mechanical pulses. These pulses advance a flat-tipped micropipette with 6μm outer diameter through the zona pellucida and oolemma with minimal deformation.

*Fundamental difference compared to Conventional ICSI:*  
1. *Oolemma rupture mechanism*: Conventional ICSI requires aspiration of ooplasm into the pipette to mechanically rupture the membrane. Piezo-ICSI achieves membrane breakage via localized piezoelectric pulses without aspiration.  
2. *Pipette design*: Conventional ICSI uses a sharpened spiking needle with cutting action. Piezo-ICSI uses a flat blunt pipette with micro-vibration drilling.  
3. *Mechanical deformation*: Conventional needle causes significant oocyte deformation and spindle displacement, while Piezo-ICSI maintains oocyte sphericity.

*2. Clinical Results Derived from Studies*  
The studies included 69 patients undergoing microinjection, 947 mature oocytes, and 137 women in a sibling oocyte design.

*1. Fertilization Rates and Oocyte Integrity*
**Measured Parameter**    **Conventional ICSI**    **Piezo-ICSI**    **Statistical Significance**
Two-pronuclei fertilization rate 2PN    65.8% ± 2.3% and 70.1%    80.5% ± 2.4% and 75.4%    P < 0.0001 and P = 0.008
Oocyte degeneration rate    8.6% ± 1.2% and 6.4%    4.4% ± 1.3% and 0.0%    P = 0.019 and P = 0.0446
Abnormal fertilization 1PN + 3PN    7.4% ± 1.1%    2.9% ± 1.1%    P = 0.003
Oocyte survival post-injection    94.3%    95.2%    Not significant
*2. Embryo Development and Quality*
**Study Group**    **Blastocyst Formation Day 5-6**    **High-Grade Blastocysts Grade A+B**    **Mean Usable Embryos per Cycle**
All age groups    54.9% vs 50.2%    33.3% vs 27.5%, P = 0.019    3.8 ± 0.2 vs 3.1 ± 0.2, P = 0.038
Women >35 years    52.4% vs 39.6%, P = 0.016    Significant improvement    Increase of one usable embryo per cycle
Women ≤35 years    58.3% vs 61.7%    No significant difference    No significant difference
*3. Pregnancy and Live Birth Rates*  
- No statistically significant difference in clinical pregnancy rate per fresh transfer: 57.1% Piezo-ICSI vs 60.0% conventional ICSI, attributed to underpowered studies.  
- Blastocyst grade correlates directly with implantation: Grade A 77%, Grade B 44%, Grade C 20%.  
- The primary clinical advantage of Piezo-ICSI lies in increased availability of high-grade embryos for cryopreservation, thereby enhancing cumulative pregnancy rates across multiple transfers.

*3. Patient Groups with Maximum Benefit*  
Based on subgroup analysis of the three studies:  
1. *Women aged 35 years and above*: Recorded the greatest improvement in fertilization rate with P = 0.008 and blastocyst development with P = 0.016. In the ≥38 years subgroup, degeneration decreased to 0.0% vs 6.4% with conventional ICSI.  
2. *Poor ovarian responders*: Patients with prior cycles showing fertilization below 50% or embryo utilization below 20% with conventional ICSI.  
3. *Low oocyte yield*: When ≤6 mature oocytes are retrieved, reducing degeneration from 12.1% to 6.3% critically impacts final outcome.  
4. *Repeated fertilization failure*: Fragile oocytes unresponsive to sharp needle cutting respond more effectively to micro-vibration drilling.

In women aged 35 years and below, no significant differences were observed between techniques due to inherent oocyte robustness.

*4. Biological Explanation for Reduced Oocyte Damage*  
1. *Elimination of ooplasm aspiration*: Aspiration in conventional ICSI displaces the meiotic spindle and stresses intracellular structures. Piezo-ICSI bypasses this step through pulse-mediated membrane rupture.  
2. *Minimization of mechanical deformation*: The cutting and twisting action of sharp needles deforms the membrane and increases calcium permeability, whereas micro-vibration drilling penetrates while preserving spherical geometry.  
3. *Reduction of membrane breach area*: The flat tip creates a precise micro-opening compared to the irregular tear from sharp needles, decreasing structural damage.

*5. Technical Considerations and Current Limitations*  
1. *Equipment*: Requires Piezo PMM4G system and ultrathin PINU06-20FT pipettes, plus specialized embryologist training.  
2. *Live birth per transfer*: No proven significant difference in randomized trials to date. Primary benefit remains increased embryo inventory.  
3. *Long-term data*: Ongoing collection of cumulative pregnancy rate data across multiple treatment cycles.  
4. *Availability*: Not yet adopted in all IVF centers and currently offered through special access programs in select countries.

*6. Conclusion*  
Piezo-ICSI represents a mechanically less invasive microinjection method. Clinical studies demonstrate its superiority in increasing fertilization rates, reducing oocyte loss, and generating more high-grade embryos. Its clinical advantage is most evident in women over 35 years, poor responders, and patients with limited oocyte numbers. Conversely, outcomes converge with conventional ICSI in younger women with robust and abundant oocytes. Consultation with the treating physician is advised regarding availability and suitability for the individual case.

Dr Najeeb Layyous  F.R.C.O.G

Consultant Obstetrician, Gynecologist and Infertility Specialist